REPLIGEN CORP Gain on Purchase of Business (Deprecated 2013-01-31)
REPLIGEN CORP (RGEN) reported Gain on Purchase of Business (Deprecated 2013-01-31) of $314.24 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Income Statement › Other Income
us-gaap:GainOnPurchaseOfBusiness · last filed 2013-05-07
- REPLIGEN CORP gain on purchase of business (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- REPLIGEN CORP gain on purchase of business (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $0.00.
- REPLIGEN CORP gain on purchase of business (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $0.00.
- REPLIGEN CORP gain on purchase of business (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $314.24K.
- REPLIGEN CORP gain on purchase of business (deprecated 2013-01-31) for fiscal 2012 was $314.24K.
| Period end | Gain on Purchase of Business (Deprecated 2013-01-31) 3 month | Gain on Purchase of Business (Deprecated 2013-01-31) 6 month | Gain on Purchase of Business (Deprecated 2013-01-31) 9 month | Gain on Purchase of Business (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | $0.00 derived: sum of 3 quarters · filed 2013-03-15 | $314.24K 10-K · filed 2013-03-15 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $314.24K 10-Q · filed 2012-11-08 | $741.24K derived: sum of 4 quarters · filed 2013-05-07 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $314.24K 10-Q · filed 2012-08-09 | $741.24K derived: sum of 3 quarters · filed 2013-05-07 | |
| 2012-03-31 | $314.24K 10-Q · filed 2013-05-07 | $741.24K derived: sum of 2 quarters · filed 2013-05-07 | ||
| 2011-12-31 | $427.00K 10-K · filed 2013-03-15 | $427.48K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |